Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DFL24412 versus ketoprofen lysine salt in chronic low back pain
2021-001629-38Phase 2Active
- Sponsor
- Dompé
- Start
- Sep 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of DFL24412 and ketoprofen lysine salt in chronic low back pain (CLBP) (3 arms), sponsored by Dompé. Primary endpoint: Change from baseline in average daily low back pain intensity at Week 2. Started Sep 2021; status: active.
02
Drugs
DFL24412ketoprofen lysine salt
03
Conditions
chronic low back pain (CLBP)
Beyond the preview
Go deeper on 2021-001629-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-001629-38.